What is KPV?
KPV is a tripeptide of three amino acids, Lysine (K), Proline (P) and Valine (V), taken from the C-terminal end of alpha-melanocyte-stimulating hormone (α-MSH). Alpha-MSH is made in the pituitary gland and has well-documented anti-inflammatory and immunomodulatory effects. KPV keeps most of that anti-inflammatory activity in a smaller, more stable form.
The small size matters: tripeptides survive the digestive tract better than larger peptides, so oral dosing is a plausible route, especially for gut-targeted effects. That makes KPV interesting for inflammatory bowel conditions, where local action in the gut is the goal rather than systemic delivery.
Most of the research focuses on Crohn's disease, ulcerative colitis and other inflammatory bowel disease, plus psoriasis, wound healing and gut-barrier integrity (the “leaky gut” mechanism).
Effects, what does the research say?
Most KPV studies are in cell culture and rodent models. That matters: the mechanistic evidence is strong and well-reproduced, but large human trial data is still limited. The animal results are solid and have been replicated across several independent labs.
Gut Inflammation & Colitis
The most-studied use of KPV is in inflammatory bowel conditions. Animal research, mostly in mouse colitis models, shows:
- Lower intestinal inflammation markers (TNF-α, IL-1β, IL-6)
- Reduced macroscopic damage to colon tissue
- Improved gut barrier function and reduced intestinal permeability
“KPV, the C-terminal tripeptide of alpha-MSH, mediates potent anti-inflammatory effects in mouse colitis models, acting directly on intestinal epithelial cells and macrophages to reduce pro-inflammatory cytokine expression.”
Dalmasso G et al. (2008), The Peptide KPV Mediates Anti-Inflammatory Effects in Mouse Colitis via the Melanocortin 1 Receptor. American Journal of Pathology. · PMID 18061177 ↗
Mechanism, Melanocortin Receptor Action
KPV works primarily by activating MC1R (melanocortin 1 receptor) on immune cells and epithelial cells:
- Reduces NF-κB activation, the main regulator of inflammatory gene expression
- Suppresses release of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6, IL-8)
- Activates anti-inflammatory pathways (IL-10 upregulation)
- Mast cell stabilisation: reduces histamine release relevant to allergic inflammation
Skin Inflammation
Beyond the gut, KPV has been studied for skin conditions driven by chronic inflammation:
- Psoriasis and atopic dermatitis models show reduced inflammatory cytokine production
- Wound healing: KPV accelerates skin wound closure in animal models
- Topical formulations studied, with nanoparticle delivery improving skin penetration
- The melanocortin pathway is well-established in skin immunology
“Alpha-MSH and its C-terminal tripeptide KPV have consistently demonstrated anti-inflammatory activity in peripheral tissues, particularly skin and gut, through modulation of NF-κB and cytokine pathways.”
Bonfiglio V et al. (2006), Effects of the COOH-terminal tripeptide alpha-MSH(11-13) on corneal epithelial wound healing. Experimental Eye Research. · PMID 16965771 ↗
Gut Permeability (“Leaky Gut”)
KPV research extends to the gut barrier itself:
- Strengthens tight junction proteins (claudin, occludin, ZO-1) that form the gut barrier
- Reduces intestinal permeability in stress and inflammation models
- Potential relevance for conditions beyond IBD: IBS, SIBO recovery, post-antibiotic gut repair
Dosage, what is being researched?
Important: There is no officially approved human dosage for KPV. The following reflects what is documented in published research and what research settings report; this is not medical advice.
| Application | Typical Dose | Route | Duration |
|---|---|---|---|
| Gut inflammation | 500 mcg, 1 mg/day | Oral (capsule or dissolved) | 4-8 weeks |
| Systemic anti-inflammatory | 500 mcg, 1 mg/day | Subcutaneous injection | 4-6 weeks |
| Skin (topical) | 0.1-0.5% cream | Topical application | 4-12 weeks |
Storage & Reconstitution
- Unreconstituted: Refrigerator (2-8 °C), protected from light, up to 24 months
- After reconstitution with bacteriostatic water: max. 30 days refrigerated
- Do not freeze after reconstitution
- Add water slowly along the glass wall, do not shake